← All news
Markets
Key HIV stat over 70% leaves BofA siding with Gilead
2 outlets - including Yahoo and Thestreet - are covering this story. Gilead Sciences (GILD) closed a strong second quarter, and Wall Street noticed. The drugmaker beat sales expectations across its biggest franchises, raised its full-year outlook, and gave analysts fresh reasons to stay bullish heading into…
Covered by 2 outlets
All coverage · 2 articles
Yahoo Finance News
·Aug 8, 14:07 UTC
Key HIV stat over 70% leaves BofA siding with Gilead
TheStreet
·Aug 8, 11:07 UTC
Key HIV stat over 70% leaves BofA siding with Gilead
Gilead Sciences (GILD) closed a strong second quarter, and Wall Street noticed. The drugmaker beat sales expectations across its biggest franchises, raised its full-year outlook, and gave analysts fresh reasons to stay bullish heading into…